ZA200904148B - Pyrrolo [1,2-A]imidazoledione effective in the treatment of peripheral neurotoxicity induced by chemotherapeutic agents - Google Patents

Pyrrolo [1,2-A]imidazoledione effective in the treatment of peripheral neurotoxicity induced by chemotherapeutic agents

Info

Publication number
ZA200904148B
ZA200904148B ZA200904148A ZA200904148A ZA200904148B ZA 200904148 B ZA200904148 B ZA 200904148B ZA 200904148 A ZA200904148 A ZA 200904148A ZA 200904148 A ZA200904148 A ZA 200904148A ZA 200904148 B ZA200904148 B ZA 200904148B
Authority
ZA
South Africa
Prior art keywords
imidazoledione
pyrrolo
effective
treatment
chemotherapeutic agents
Prior art date
Application number
ZA200904148A
Other languages
English (en)
Inventor
Carlo Farina
Carla Ghelardini
Paola Petrillo
Original Assignee
Neurotune Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37882430&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200904148(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Neurotune Ag filed Critical Neurotune Ag
Publication of ZA200904148B publication Critical patent/ZA200904148B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA200904148A 2006-11-15 2009-06-12 Pyrrolo [1,2-A]imidazoledione effective in the treatment of peripheral neurotoxicity induced by chemotherapeutic agents ZA200904148B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06124142A EP1925304A1 (de) 2006-11-15 2006-11-15 Pyrrolo[1,2-a]imidazoledione zur Behandlung von durch Chemotherapie ausgelöster peripherer Neuropathie

Publications (1)

Publication Number Publication Date
ZA200904148B true ZA200904148B (en) 2010-04-28

Family

ID=37882430

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200904148A ZA200904148B (en) 2006-11-15 2009-06-12 Pyrrolo [1,2-A]imidazoledione effective in the treatment of peripheral neurotoxicity induced by chemotherapeutic agents

Country Status (19)

Country Link
US (1) US7973066B2 (de)
EP (2) EP1925304A1 (de)
JP (1) JP2010509389A (de)
CN (1) CN101605541A (de)
AR (1) AR063819A1 (de)
AT (1) ATE478668T1 (de)
AU (1) AU2007321218A1 (de)
BR (1) BRPI0718904A2 (de)
CA (1) CA2669853A1 (de)
CL (1) CL2007003281A1 (de)
DE (1) DE602007008759D1 (de)
EA (1) EA200900552A1 (de)
ES (1) ES2347380T3 (de)
IL (1) IL198689A0 (de)
MX (1) MX2009005125A (de)
NZ (1) NZ576995A (de)
PE (1) PE20081494A1 (de)
WO (1) WO2008058988A1 (de)
ZA (1) ZA200904148B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20030573A1 (it) * 2003-03-24 2004-09-25 Nikem Research Srl Composti ad azione nootropica, loro preparazione,
US9125898B2 (en) 2008-11-14 2015-09-08 Neurotune Ag Acetam derivatives for pain relief
KR20170036753A (ko) * 2014-07-31 2017-04-03 글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 화학요법 유도된 말초 신경병증 (cipn)의 예방 및/또는 치료를 위한 cxcr2 길항제의 용도
PL4025183T3 (pl) * 2019-09-02 2025-09-22 Syddansk Universitet Induktory P-gp do stosowania w ochronie przed skutkami ubocznymi chemioterapii takimi jak neuropatia obwodowa wywołana chemioterapią (CIPN) oraz utrata włosów

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20030573A1 (it) * 2003-03-24 2004-09-25 Nikem Research Srl Composti ad azione nootropica, loro preparazione,

Also Published As

Publication number Publication date
EP2094265B1 (de) 2010-08-25
US7973066B2 (en) 2011-07-05
DE602007008759D1 (de) 2010-10-07
AU2007321218A1 (en) 2008-05-22
PE20081494A1 (es) 2008-12-19
EP2094265A1 (de) 2009-09-02
EP1925304A1 (de) 2008-05-28
CA2669853A1 (en) 2008-05-22
IL198689A0 (en) 2010-02-17
NZ576995A (en) 2010-12-24
CL2007003281A1 (es) 2008-06-27
BRPI0718904A2 (pt) 2013-12-10
ES2347380T3 (es) 2010-10-28
EA200900552A1 (ru) 2009-10-30
US20100062077A1 (en) 2010-03-11
CN101605541A (zh) 2009-12-16
ATE478668T1 (de) 2010-09-15
MX2009005125A (es) 2009-11-02
WO2008058988A1 (en) 2008-05-22
AR063819A1 (es) 2009-02-18
JP2010509389A (ja) 2010-03-25

Similar Documents

Publication Publication Date Title
IL186616A0 (en) Spiro-oxindole compounds and their uses as therapeutic agents
IL249651A0 (en) Salts of 2-fluoro-n-methyl-4-[7-(quinolin-6-yl-methyl)-imidazo[b-2,1] 4,2,1]]triazin-2-yl]benzamide and processes related to their preparation
IL186615A0 (en) Spiroheterocylic compounds and their uses as therapeutic agents
GB0410725D0 (en) Pyrrolobenzodiazepine therapeutic agents
PL1978947T3 (pl) Nitrooksypochodne do zastosowania w leczeniu dystrofii mięśniowych
IL182261A0 (en) Therapeutic agents with decreased toxicity
IL200695A (en) History of Hydro-Oxazolo [2,3-a] Pyrimidine-7-Wen and Pharmaceutical Preparations Containing Them
IL195906A0 (en) Alpha-aminoamide derivatives useful in the treatment of cognitive disorders
IL206466A0 (en) PYRAZOLO [1,5-a]PYRIMIDINES, COMPOSITIONS COMPRISING THE SAME AND USES THEREOF
IL198239A0 (en) Substituted 8-piperidinyl-2-pyridinyl-pyrimido [1,2-a] pyrimidin -6- one and 8-piperidinyl-2- pyrimidinyl [1,2-a] pyrimidin -6- one derivatives
IL178816A0 (en) The treatment of childhood asthma
ZA200801893B (en) Amorphous solid dispersions of 7-chloro-N,N, 5-Trimethyl-4-Oxo-3-phenyl-3, 5,-dihydro-4H-pyridazino [4,5-B] indole-1-acetamide
IL198481A0 (en) Pyrrole derivatives, preparation use of the same in therapy
IL198689A0 (en) Pyrrolo [1,2-a] imidazoledione effective in the treatment of peripheral neurotoxicity induced by chemotheraupeutic agents
IL195949A0 (en) Use of derivatives of imidazo[1,2-a]pyridine-2-carboxamides in therapeutics
ZA200703478B (en) Therapeutic agents with decreased toxicity
PL2059521T3 (pl) Pirazolo[1,5-A]pirymidyny,sposoby, zastosowanie i kompozycje
ZA200700630B (en) Triazolopyrimidine compounds and their use for controlling pathogenic fungi
GB2453116B (en) Uses of 2-[piperidinyl]methy1-2,3-dihydroimidazo[1,2-c]quinazolin-5(6H)-one in providing an analgesic effect
IL179256A0 (en) Triazolopyrimidine compounds and their use for controlling pathogenic fungi
HU0400429D0 (en) Body spray
HK1119954A (en) Use of neboglamine in the treatment of toxicodependency
EP1956001A4 (de) Pharmazeutikum zur verwendung bei der behandlung von ureterolithiasis
PH32005000539S1 (en) Skin treatment articles
PH32005000542S1 (en) Skin treatment articles